1 Min Read
June 27 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says Glenmark Pharmaceuticals receives ANDA approval for indomethacin extended-release capsules USP, 75 mg Source text - (bit.ly/2tPUBQk) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.